je.st
news
Tag: drug
Drug Delivery Platform offers intrinsic enteric protection.
2015-12-02 14:31:06| Industrial Newsroom - All News for Today
Leveraging unique combination of formulation and polymer chemistry, enTRinsic™ drug delivery technology platform provides full enteric protection and targeted release of gastric acid- and heat-sensitive active ingredients to upper gastrointestinal tract, without need for functional coatings. Technology enables oral delivery of variety of compounds — including vaccines, proteins, and peptides — using pharmaceutically approved enteric polymers.
Tags: offers
delivery
protection
drug
Presage Biosciences In-Licenses Clinical Stage Drug Program
2015-12-02 02:08:44| drugdiscoveryonline Home Page
Presage Biosciences, an oncology company pioneering a radical new drug development approach that incorporates human efficacy data much earlier in development and clinical trials, announced recently that it has in-licensed voruciclib, its first clinical stage drug program
Tags: program
stage
drug
clinical
Sosei Subsidiary Heptares Enters Strategic Drug Discovery Collaboration With Pfizer Inc. Focused On GPCR Targets Across Multiple Therapeutic Areas
2015-12-02 01:37:23| drugdiscoveryonline Home Page
Sosei Group Corporation (“Sosei”) recently announces that its wholly-owned subsidiary, Heptares Therapeutics has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas
Tags: areas
multiple
drug
focused
Senate investigation: Maker of breakthrough drug for hepatitis C sought to maximize revenue
2015-12-01 18:05:31| Biotech - Topix.net
The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, Senate investigators said Tuesday. A bipartisan report from the Senate Finance Committee concluded that California-based Gilead Sciences was focused on maximizing revenue even as the company's own analysis showed a lower price would allow more patients to be treated.
Tags: to
drug
investigation
revenue
FDA Approves Blood Cancer Drug
2015-12-01 00:27:14| Biotech - Topix.net
The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. The FDA said it approved the treatment, Empliciti, to be used in multiple myeloma patients in combination with Celgene Corp's Revlimid and common anti-inflammatory drug dexamethasone.
Sites : [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] next »